speb/financial-data huggingface dataset:
BMA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -583867000.00
BMA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -48133863000.00
BMA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -571955590000.00
BMA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 204791898000.00
BMA cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -158185472000.00
BMA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 971163216000.00
BMA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -990252873000.00
BMA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -620673320000.00
BMA balance_sheet (quarterly, 2025-03-31) — Common Stock: 639413000.00
BMA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4439132964000.00
BMA balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 34896343000.00
BMA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 96355259000.00
BMA balance_sheet (quarterly, 2025-03-31) — Current Provisions: 14753077000.00
BMA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 49188567000.00
BMA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 49188567000.00
BMA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 49188567000.00
BMA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 49188567000.00
BMA income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 49188567000.00
BMA balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 1002657000.00
BMA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-03-31) — Diluted EPS: 930.13
BMA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 59473847000.00
BMA balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1229000.00
BMA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 109540737000.00
BMA balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 5134013000.00
BMA cash_flow (quarterly, 2025-03-31) — End Cash Position: 3309366397000.00
BMA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -583867000.00
BMA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -620089453000.00
BMA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 88087001000.00
BMA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2681196177000.00
BMA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 329429385000.00
BMA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 160927410000.00
BMA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1179689300000.00
BMA balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 175983256000.00
BMA income_statement (quarterly, 2025-03-31) — Insurance And Claims: 15710020000.00
BMA income_statement (quarterly, 2025-03-31) — Interest Expense: 383115140000.00
BMA income_statement (quarterly, 2025-03-31) — Interest Income: 1135639488000.00
BMA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4896586336000.00
BMA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -48133863000.00
BMA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 4455222761000.00
BMA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 3210220000.00
BMA balance_sheet (quarterly, 2025-03-31) — Leases: 79546852000.00
BMA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 16804007000.00
BMA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 457453372000.00
BMA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 474257379000.00
BMA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 3210220000.00
BMA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3794087000.00
BMA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 4176396000.00
BMA balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3236225000.00
BMA balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 260603944000.00
BMA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3099861000.00
BMA income_statement (quarterly, 2025-03-31) — Minority Interests: -1127305000.00
BMA cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -82994822000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income: 59473847000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 59473847000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 60601152000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 59473847000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 59473847000.00
BMA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 106289158000.00
BMA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 60601152000.00
BMA income_statement (quarterly, 2025-03-31) — Net Interest Income: 752524348000.00
BMA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -583867000.00
BMA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -583867000.00
BMA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2746934000.00
BMA balance_sheet (quarterly, 2025-03-31) — Net PPE: 856881384000.00
BMA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -48133863000.00
BMA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4278205554000.00
BMA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 113739940000.00
BMA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 113739940000.00
BMA balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 5134013000.00
BMA income_statement (quarterly, 2025-03-31) — Normalized Income: 289793655550.00
BMA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -571955590000.00
BMA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -82994822000.00
BMA income_statement (quarterly, 2025-03-31) — Operating Revenue: 1074994960000.00
BMA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 639413408.00
BMA cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -302111896000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2681196177000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1358987247000.00
BMA income_statement (quarterly, 2025-03-31) — Other Gand A: 84104670000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 160927410000.00
BMA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 262944766000.00
BMA income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 163818814000.00
BMA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -267133801000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Payable: 880379485000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Properties: 804642161000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Receivables: 414681931000.00
BMA balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 355522177000.00
BMA income_statement (quarterly, 2025-03-31) — Other Special Charges: 354338167000.00
BMA balance_sheet (quarterly, 2025-03-31) — Payables: 1056363970000.00
BMA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1152719229000.00
BMA balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 42485492000.00
BMA income_statement (quarterly, 2025-03-31) — Pretax Income: 106289158000.00
BMA income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 9767000000.00
BMA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -48133863000.00
BMA balance_sheet (quarterly, 2025-03-31) — Receivables: 498685344000.00
BMA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 49188567000.00
BMA income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 617240000.00
BMA income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 617240000.00
BMA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3794087000.00
BMA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 385880346000.00
BMA income_statement (quarterly, 2025-03-31) — Salaries And Wages: 228997455000.00
BMA income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 9745872000.00
BMA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 339175257000.00
BMA balance_sheet (quarterly, 2025-03-31) — Share Issued: 639413408.00
BMA income_statement (quarterly, 2025-03-31) — Special Income Charges: -354338167000.00
BMA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4439132964000.00
BMA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4278205554000.00
BMA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -124018358450.00
BMA income_statement (quarterly, 2025-03-31) — Tax Provision: 45688006000.00
BMA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.35
BMA cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -4613022000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Assets: 16144043071000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4896586336000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Debt: 474257379000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4442232825000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11701810246000.00
BMA balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 175983256000.00
BMA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -354338167000.00
BMA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -354338167000.00
BMA income_statement (quarterly, 2025-06-30) — +Total Revenue: 1017650814000.00
BMA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 153892440000.00
BMA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -358765009000.00
BMA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 4480579788000.00
BMA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-06-30) — Basic EPS: 2332.40
BMA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3309366397000.00
BMA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -25865478000.00
BMA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 19143566000.00
BMA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2578019213000.00
BMA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 2619945724000.00
BMA balance_sheet (quarterly, 2025-06-30) — Cash Financial: 366757281000.00
BMA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 422082753000.00
BMA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -25865478000.00
BMA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -331889323000.00
BMA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -170759693000.00
BMA cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 271164635000.00
BMA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -85409654000.00
BMA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -733934031000.00
BMA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 64327952000.00
BMA balance_sheet (quarterly, 2025-06-30) — Common Stock: 639413000.00
BMA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4515765900000.00
BMA balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 45777931000.00
BMA balance_sheet (quarterly, 2025-06-30) — Current Provisions: 14867537000.00
BMA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 29316307000.00
BMA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 39181020000.00
BMA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 29316307000.00
BMA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 39181020000.00
BMA income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 39181020000.00
BMA balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 663597000.00
BMA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-06-30) — Diluted EPS: 2332.40
BMA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 149136905000.00
BMA balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 306083000000.00
BMA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 145920296000.00
BMA balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 9233515000.00
BMA cash_flow (quarterly, 2025-06-30) — End Cash Position: 2606752080000.00
BMA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 422082753000.00
BMA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -357754801000.00
BMA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 113717004000.00
BMA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2863701830000.00
BMA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 263110846000.00
BMA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 168020048000.00
BMA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1269893986000.00
BMA balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 236793739000.00
BMA income_statement (quarterly, 2025-06-30) — Insurance And Claims: 7076311000.00
BMA income_statement (quarterly, 2025-06-30) — Interest Expense: 392368335000.00
BMA income_statement (quarterly, 2025-06-30) — Interest Income: 1093764719000.00
BMA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5479572179000.00
BMA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -25865478000.00
BMA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4770441144000.00
BMA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 473840382000.00
BMA balance_sheet (quarterly, 2025-06-30) — Leases: 87019025000.00
BMA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 19143566000.00
BMA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 963806279000.00
BMA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 982949845000.00
BMA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 473840382000.00
BMA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -12357786000.00
BMA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4449484000.00
BMA balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3249644000.00
BMA balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 282072464000.00
BMA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 2892983000.00
BMA income_statement (quarterly, 2025-06-30) — Minority Interests: -403548000.00
BMA cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -83853035000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income: 149136905000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 149136905000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 149540453000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 149136905000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 149136905000.00
BMA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 224005364000.00
BMA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 149540453000.00
BMA income_statement (quarterly, 2025-06-30) — Net Interest Income: 701396384000.00
BMA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 461482596000.00
BMA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 461482596000.00
BMA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2673918000.00
BMA balance_sheet (quarterly, 2025-06-30) — Net PPE: 911128977000.00
BMA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -25865478000.00
BMA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4347745852000.00
BMA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 175780878000.00
BMA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 175780878000.00
BMA balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 9233515000.00
BMA income_statement (quarterly, 2025-06-30) — Normalized Income: 149285329003.25
BMA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -331889323000.00
BMA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -83853035000.00
BMA income_statement (quarterly, 2025-06-30) — Operating Revenue: 1017650814000.00
BMA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 639413408.00
BMA cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: -86077363000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2863701830000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1441483649000.00
BMA income_statement (quarterly, 2025-06-30) — Other Gand A: 68736790000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 168020048000.00
BMA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 163632400000.00
BMA income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 155551569000.00
BMA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -203936999000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Payable: 1179934457000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Properties: 855024566000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Receivables: 384666716000.00
BMA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 285411872000.00
BMA income_statement (quarterly, 2025-06-30) — Other Special Charges: 204078253000.00
BMA balance_sheet (quarterly, 2025-06-30) — Payables: 1722811196000.00
BMA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1722811196000.00
BMA balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 55391909000.00
BMA income_statement (quarterly, 2025-06-30) — Pretax Income: 245321539000.00
BMA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -25865478000.00
BMA balance_sheet (quarterly, 2025-06-30) — Receivables: 538559156000.00
BMA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 29316307000.00
BMA income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 184456000.00
BMA income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 184456000.00
BMA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -12357786000.00
BMA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 197511227000.00
BMA income_statement (quarterly, 2025-06-30) — Salaries And Wages: 187113289000.00
BMA income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 7802175000.00
BMA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 270913021000.00
BMA balance_sheet (quarterly, 2025-06-30) — Share Issued: 639413408.00
BMA income_statement (quarterly, 2025-06-30) — Special Income Charges: -204078253000.00
BMA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4515765900000.00
BMA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4347745852000.00
BMA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -95065996.75
BMA income_statement (quarterly, 2025-06-30) — Tax Provision: 95781086000.00
BMA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
BMA cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -16550392000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Assets: 18457043362000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 5479572179000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Debt: 982949845000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4518658883000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 13938384479000.00
BMA balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 236793739000.00
BMA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -243490000.00
BMA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -243490000.00
BMA income_statement (quarterly, 2025-09-30) — +Total Revenue: 870501370000.00
BMA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 291818478000.00
BMA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -392717316000.00
BMA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 4651013430000.00
BMA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-09-30) — Basic EPS: -517.61
BMA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2606752080000.00
BMA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -45194597000.00
BMA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 19439589000.00
BMA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3367816300000.00
BMA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 3367816300000.00
BMA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -109696886000.00
BMA balance_sheet (quarterly, 2025-09-30) — Cash Financial: 356793284000.00
BMA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 120847071000.00
BMA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -45194597000.00
BMA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 515682428000.00
BMA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -112419443000.00
BMA cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 82142700000.00
BMA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 767660788000.00
BMA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 290173494000.00
BMA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 591334902000.00
BMA balance_sheet (quarterly, 2025-09-30) — Common Stock: 639413000.00
BMA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -109696886000.00
BMA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4756885134000.00
BMA balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 46408909000.00
BMA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 168867122000.00
BMA balance_sheet (quarterly, 2025-09-30) — Current Provisions: 24232769000.00
BMA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 46471072000.00
BMA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 41785690000.00
BMA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 46471072000.00
BMA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 41785690000.00
BMA balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 3141510000.00
BMA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-09-30) — Diluted EPS: -517.61
BMA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -33096844000.00
BMA balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 215185211000.00
BMA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 290208330000.00
BMA balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 4584199000.00
BMA cash_flow (quarterly, 2025-09-30) — End Cash Position: 3481404304000.00
BMA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 120847071000.00
BMA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 470487831000.00
BMA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 19530126000.00
BMA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 3039318283000.00
BMA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 314259557000.00
BMA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 173240066000.00
BMA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1358756250000.00
BMA balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 209532324000.00
BMA income_statement (quarterly, 2025-09-30) — Insurance And Claims: 9618082000.00
BMA income_statement (quarterly, 2025-09-30) — Interest Expense: 547150102000.00
BMA income_statement (quarterly, 2025-09-30) — Interest Income: 1224996169000.00
BMA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6042979244000.00
BMA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -45194597000.00
BMA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 4769655274000.00
BMA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 255435439000.00
BMA balance_sheet (quarterly, 2025-09-30) — Leases: 86259029000.00
BMA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 19439589000.00
BMA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1286094110000.00
BMA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1305533699000.00
BMA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 255435439000.00
BMA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -19754950000.00
BMA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 5254996000.00
BMA balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 5297958000.00
BMA balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 310328711000.00
BMA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3097194000.00
BMA income_statement (quarterly, 2025-09-30) — Minority Interests: -31550000.00
BMA cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -125939907000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income: -33096844000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -33096844000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -33065294000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -33096844000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -33096844000.00
BMA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -18315702000.00
BMA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -33065294000.00
BMA income_statement (quarterly, 2025-09-30) — Net Interest Income: 677846067000.00
BMA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 235680489000.00
BMA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 235680489000.00
BMA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -5136532000.00
BMA balance_sheet (quarterly, 2025-09-30) — Net PPE: 966038934000.00
BMA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -45194597000.00
BMA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4583645068000.00
BMA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 209350029000.00
BMA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 209350029000.00
BMA balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 4584199000.00
BMA income_statement (quarterly, 2025-09-30) — Normalized Income: -32562678102.06
BMA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 515682428000.00
BMA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -125939907000.00
BMA income_statement (quarterly, 2025-09-30) — Operating Revenue: 870501370000.00
BMA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 639413408.00
BMA cash_flow (quarterly, 2025-09-30) — Other Cash Adjustment Outside Changein Cash: -203594741000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 3039318283000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1528295272000.00
BMA income_statement (quarterly, 2025-09-30) — Other Gand A: 72763965000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 173240066000.00
BMA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 165000173000.00
BMA income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 182022465000.00
BMA income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -203078596000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Payable: 1147240346000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Properties: 915759601000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Receivables: 346912761000.00
BMA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 113386848000.00
BMA income_statement (quarterly, 2025-09-30) — Other Special Charges: 554234000.00
BMA balance_sheet (quarterly, 2025-09-30) — Payables: 1571957881000.00
BMA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1740825003000.00
BMA balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 53662084000.00
BMA income_statement (quarterly, 2025-09-30) — Pretax Income: -38028568000.00
BMA income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 11001000000.00
BMA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -45194597000.00
BMA balance_sheet (quarterly, 2025-09-30) — Receivables: 638731239000.00
BMA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 46471072000.00
BMA income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 456417000.00
BMA income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 456417000.00
BMA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -19754950000.00
BMA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 176202385000.00
BMA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 231421093000.00
BMA income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 8874764000.00
BMA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 323134321000.00
BMA balance_sheet (quarterly, 2025-09-30) — Share Issued: 639413408.00
BMA income_statement (quarterly, 2025-09-30) — Special Income Charges: -554234000.00
BMA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4756885134000.00
BMA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4583645068000.00
BMA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -80181102.06
BMA income_statement (quarterly, 2025-09-30) — Tax Provision: -4963274000.00
BMA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.13
BMA cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -10666479000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Assets: 20562862688000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6042979244000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Debt: 1305533699000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4759982328000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 15802880360000.00
BMA balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 209532324000.00
BMA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -614347000.00
BMA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -614347000.00
BMA income_statement (quarterly, 2025-12-31) — +Total Revenue: 1498732621000.00
BMA income_statement (annual, 2025-12-31) — Basic Average Shares: 63940900.00
BMA income_statement (annual, 2025-12-31) — Basic EPS: 4527.54
BMA income_statement (annual, 2025-12-31) — Diluted Average Shares: 63940900.00
BMA income_statement (annual, 2025-12-31) — Diluted EPS: 4527.54
BMA income_statement (quarterly, 2025-12-31) — Operating Revenue: 1498732621000.00
BMA income_statement (quarterly, 2025-12-31) — Other Special Charges: 336980265000.00
BMA income_statement (quarterly, 2025-12-31) — Special Income Charges: -336980265000.00
BMA income_statement (quarterly, 2026-03-31) — +Total Revenue: 1404539445000.00
BMA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 400745573000.00
BMA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -501262474000.00
BMA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 6197193572000.00
BMA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 63939000.00
BMA income_statement (quarterly, 2026-03-31) — Basic EPS: 2193.32
BMA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4945545627000.00
BMA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -30572337000.00
BMA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 15889327000.00
BMA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4732047111000.00
BMA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 4833773032000.00
BMA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -72587923000.00
BMA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 521868330000.00
BMA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 40036159000.00
BMA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -30572337000.00
BMA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 624553340000.00
BMA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 56913112000.00
BMA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -300842140000.00
BMA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -948369575000.00
BMA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -246226860000.00
BMA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 634017162000.00
BMA balance_sheet (quarterly, 2026-03-31) — Common Stock: 639413000.00
BMA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -72587923000.00
BMA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5855969445000.00
BMA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 56536114000.00
BMA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 57946623000.00
BMA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 46660216000.00
BMA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 46660216000.00
BMA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 46660216000.00
BMA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 46660216000.00
BMA income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 46660216000.00
BMA balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 5358270000.00
BMA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 63939000.00
BMA income_statement (quarterly, 2026-03-31) — Diluted EPS: 2193.32
BMA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 140238562000.00
BMA balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 13325000.00
BMA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -193940811000.00
BMA balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 103603174000.00
BMA cash_flow (quarterly, 2026-03-31) — End Cash Position: 4961323916000.00
BMA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 40036159000.00
BMA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 593981003000.00
BMA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 84367594000.00
BMA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3578428438000.00
BMA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 335216966000.00
BMA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 194477465000.00
BMA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1623360125000.00
BMA balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 696501566000.00
BMA income_statement (quarterly, 2026-03-31) — Insurance And Claims: 15904974000.00
BMA income_statement (quarterly, 2026-03-31) — Interest Expense: 502589426000.00
BMA income_statement (quarterly, 2026-03-31) — Interest Income: 1481642944000.00
BMA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7320848729000.00
BMA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -30572337000.00
BMA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 6427800297000.00
BMA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 616726744000.00
BMA balance_sheet (quarterly, 2026-03-31) — Leases: 97799483000.00
BMA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 15889327000.00
BMA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1464879284000.00
BMA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1480768611000.00
BMA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 616726744000.00
BMA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -499216192000.00
BMA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 113261492000.00
BMA balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 65105917000.00
BMA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 395297166000.00
BMA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 2831215000.00
BMA income_statement (quarterly, 2026-03-31) — Minority Interests: 480920000.00
BMA cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 105465337000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income: 140238562000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 140238562000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 139757642000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 140238562000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 140238562000.00
BMA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 212688236000.00
BMA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 139757642000.00
BMA income_statement (quarterly, 2026-03-31) — Net Interest Income: 979053518000.00
BMA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 117510552000.00
BMA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 117510552000.00
BMA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -4886470000.00
BMA balance_sheet (quarterly, 2026-03-31) — Net PPE: 1122097651000.00
BMA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -30572337000.00
BMA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5661491980000.00
BMA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1552171000.00
BMA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1552171000.00
BMA balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3769842000.00
BMA income_statement (quarterly, 2026-03-31) — Normalized Income: 324426500044.49
BMA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 624553340000.00
BMA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 105465337000.00
BMA income_statement (quarterly, 2026-03-31) — Operating Revenue: 1404539445000.00
BMA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 639390301.00
BMA cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -424298062000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3578428438000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1806370293000.00
BMA income_statement (quarterly, 2026-03-31) — Other Gand A: 81161730000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 194477465000.00
BMA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 273811799000.00
BMA income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 200804904000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Payable: 1510024170000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Properties: 1073727362000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Receivables: 181138763000.00
BMA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 117345233000.00
BMA income_statement (quarterly, 2026-03-31) — Other Special Charges: 350227751000.00
BMA balance_sheet (quarterly, 2026-03-31) — Payables: 2206539061000.00
BMA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2264485684000.00
BMA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 66870512000.00
BMA income_statement (quarterly, 2026-03-31) — Pretax Income: 212688236000.00
BMA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -30572337000.00
BMA balance_sheet (quarterly, 2026-03-31) — Receivables: 581884336000.00
BMA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 46660216000.00
BMA income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 533592000.00
BMA income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 533592000.00
BMA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -499216192000.00
BMA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 458101520000.00
BMA income_statement (quarterly, 2026-03-31) — Salaries And Wages: 237616670000.00
BMA income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 13541985000.00
BMA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 348758951000.00
BMA balance_sheet (quarterly, 2026-03-31) — Share Issued: 639413408.00
BMA income_statement (quarterly, 2026-03-31) — Special Income Charges: -350227751000.00
BMA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5855969445000.00
BMA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5661491980000.00
BMA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -96115929955.51
BMA income_statement (quarterly, 2026-03-31) — Tax Provision: 72930594000.00
BMA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.34
BMA cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -6652811000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Assets: 24200431891000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7320848729000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Debt: 1480768611000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5858800660000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 18341631231000.00
BMA balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 696501566000.00
BMA income_statement (quarterly, 2026-03-31) — Total Unusual Items: -280303868000.00
BMA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -280303868000.00
BMA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 23107.00
BMA.OL balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -2124000.00
BMA.OL income_statement (annual, 2021-12-31) — Basic Average Shares: 69819000.00
BMA.OL income_statement (annual, 2021-12-31) — Basic EPS: 2.53
BMA.OL cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -558554000.00
BMA.OL cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -558554000.00
BMA.OL cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
BMA.OL income_statement (annual, 2021-12-31) — Diluted Average Shares: 69819000.00
BMA.OL income_statement (annual, 2021-12-31) — Diluted EPS: 2.53
BMA.OL balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 414738000.00
BMA.OL income_statement (annual, 2021-12-31) — Minority Interests: 0.00
BMA.OL cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
BMA.OL income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 176341000.00
BMA.OL cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
BMA.OL cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 1000.00
BMA.OL balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 1000.00
BMA.OL balance_sheet (annual, 2021-12-31) — Other Properties: 1000.00
BMA.OL balance_sheet (annual, 2021-12-31) — Other Receivables: 5620000.00
BMA.OL balance_sheet (annual, 2021-12-31) — Prepaid Assets: 27371000.00
BMA.OL cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
BMA.OL cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
BMA.OL income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 230205000.00
BMA.OL income_statement (annual, 2022-12-31) — +Operating Expense: 1039828000.00
BMA.OL income_statement (annual, 2022-12-31) — +Total Revenue: 2508195000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 353594000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 326952000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -988260000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 34499000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2678000.00
BMA.OL cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 3558000.00
BMA.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 69819000.00
BMA.OL income_statement (annual, 2022-12-31) — Basic EPS: 6.16
BMA.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 70961000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 482715000.00
BMA.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -130514000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 84218000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 18157000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19467000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 19467000.00
BMA.OL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -69819000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Cash Financial: 19467000.00
BMA.OL cash_flow (annual, 2022-12-31) — Change In Inventory: -30522000.00
BMA.OL cash_flow (annual, 2022-12-31) — Change In Payable: 12540000.00
BMA.OL cash_flow (annual, 2022-12-31) — Change In Receivables: 66087000.00
BMA.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: 48105000.00
BMA.OL cash_flow (annual, 2022-12-31) — Changes In Cash: -33188000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Common Stock: 18157000.00
BMA.OL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -69819000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1077712000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Construction In Progress: 30972000.00
BMA.OL income_statement (annual, 2022-12-31) — Cost Of Revenue: 1327260000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Current Assets: 936718000.00